⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Global TDP-43 Antibody Market Outlook and Forecast, 2026-2032 - Market to Reach USD 508.93 Million at 12.03% CAGR as Validated Antibodies, AI-Powered Imaging, and Neurodegenerative Research Create New Growth Opportunities
globenewswire.com
ABBV
ABT
ABM
BIO
BIIB
BMRN
CRSP
DHR
EXAS
GILD
ILMN
INCY
ISRG
JNJ
LULU
MDLZ
MRK
NVS
PFE
REGN
ROST
SNPS
SRPT
STX
TMO
TSLA
VRTX
WDC
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
prnewswire.com
EYPT
REGN
Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026
globenewswire.com
REGN
Global Autoimmune Disease Therapeutics Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight
globenewswire.com
ABBV
ABCL
AZN
BIIB
BMY
EXEL
GILD
GSK
INCY
LRCX
MRK
NVS
PFE
REGN
SNY
TMO
UCB
VRTX
Global Protein Expression Market to Reach USD 7.30 Billion by 2034 at 8.8% CAGR as Rising Biopharmaceutical Development, Growing Demand for Recombinant Proteins, and Advances in Cell-Free Expression Technologies Accelerate Market Growth, Reports Maximize
prnewswire.com
TMO
AMGN
AGNC
BIO
QGEN
BIIB
GILD
REGN
BMY
MRK
SNY
LLY
ABBV
PFE
JNJ
AZN
BSX
MDLZ
GEHC
SYK
EW
ISRG
GOOG
MSFT
NVDA
AMAT
KLAC
LRCX
INTC
AMD
MU
WDC
SE
CRM
IBM
ORCL
SAP
ACN
GEN
PRG
EXAS
DXCM
ALGN
IDXX
VRTX
XRAY
CTAS
MDT
AMZN
GOOGL
CTSH
INFY
HPE
DELL
HPQ
LOGI
ADBE
CDNS
SNPS
MRVL
QCOM
NXPI
ON
ADI
TXN
MCHP
QRVO
NTAP
STX
WD
CRWD
PANW
FTNT
DDOG
SNOW
ETSY
ROKU
PYPL
MELI
JD
BABA
NTES
PDD
IQ
VIPS
NIO
LI
XPEV
RIVN
TSLA
GM
F
STLA
TM
VWAGY
HOG
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
accessnewswire.com
EYPT
REGN
Forge’s Fierce Pharma Week Delivered a Powerhouse Event with Over 3,500 Pharmaceutical and Biotech Decision-Makers and Innovators, Representing a 21% Increase in Attendees Over 2025
globenewswire.com
ABBV
ACAD
AZN
BIIB
BMY
LLY
GILD
PFE
REGN
TEVA
Alzheimer's Disease Competitive Landscape and Clinical Trial Analysis Report 2026: More Than 200 Companies and 240 Therapies Assessed
globenewswire.com
LLY
BIIB
JNJ
SNY
ALNY
ABBV
BMY
REGN
XCUR
Microfluidic Control Device Market Poised for Growth as Automation, Precision Medicine, and Lab-on-a-Chip Innovation Drive New Opportunities Through the Forecast Period
globenewswire.com
BIO
ILMN
PHG
TMO
QGEN
NVDA
AMD
MSFT
GOOGL
AMZN
INTC
MU
AMAT
LRCX
KLAC
ASML
REGN
BIIB
GILD
MRNA
PFE
JNJ
EXAS
TSLA
NIO
RIVN
PLUG
FCEL
XOM
CVX
NOC
BA
LMT
GD
RTX
IBM
QCOM
NXPI
ON
ADI
TXN
MCHP
SNPS
CDNS
WDC
ADBE
CRM
GOOG
CRSP
Cell Culture Supplements Market Set for Growth Through 2033, Fueled by Biopharma R&D, Biologics Production and Advanced Cell Therapies
globenewswire.com
TMO
DHR
GLW
REGN
AMGN
BMY
GILD
MRK
BNTX
RGEN